MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00431-004-1563-1

Медицинская библиотека · European journal of pediatrics · 2004

Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response.

Aróstegui Juan I, Solís Pilar, Aldea Anna, Cantero Teresa, Rius Josefa, Bahíllo Pilar, Plaza Susana, Vives Jordi, Gómez Samuel, Yagüe Jordi

Клинический случайСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

UNLABELLED: We investigated the cause of hereditary periodic fever syndrome in a Spanish child with recurrent long episodes of fever, migratory skin rash, myalgia, arthralgia, conjunctivitis and abdominal pain. Infectious and autoimmune causes were ruled out. No familial history was reported. Analysis of the tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene identified a missense mutation (G36E) on exon 3. The absence of this variant in the patient's parents and in controls identified it as a de novo disease-associated mutation. Clinical symptoms disappeared with administration of etanercept; however, levels of acute-phase reactants remained increased and could not be stabilised by the addition of colchicine. We believe that this patient gained some symptomatic relief with etanercept therapy, although not enough to completely avoid the risk of amyloidosis. Thus it is debatable whether etanercept alone or combined with other drugs, is the treatment of choice for patients with tumour necrosis factor receptor-associated periodic syndrome.

CONCLUSION

Since there is variability in treatment responses among different patients with tumour necrosis factor receptor-associated periodic syndrome, we suggest that a systematic evaluation of acute-phase reactants, especially SAA-1, could be useful in maintaining or modifying a given therapeutic approach in these patients.

Для цитирования: Aróstegui Juan I, Solís Pilar, Aldea Anna, Cantero Teresa, Rius Josefa, Bahíllo Pilar, Plaza Susana, Vives Jordi, Gómez Samuel, Yagüe Jordi. Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response.. European journal of pediatrics. 2004. DOI: 10.1007/s00431-004-1563-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.